Of cells and microparticles: Assets and liabilities of HLA antibody detection

Robert S. Liwski, Howard M. Gebel

Résultat de recherche: Review articleexamen par les pairs

29 Citations (Scopus)

Résumé

The evolution of antibody detection from cell-to bead-based technology has positively impacted the ability to allocate organs in a safe and timely manner. The devil, of course, is in the details that delineate how these assays are performed and applied and to recognize that while there have been some truly amazing technological advances (assets), they are still imperfect and subject to error (liabilities). This review identifies the strengths of HLA antibody assays, highlights their weaknesses and offers approaches for standardization.

Langue d'origineEnglish
Pages (de-à)S1-S6
JournalTransplantation
Volume102
Numéro de publication1S
DOI
Statut de publicationPublished - janv. 1 2018

Note bibliographique

Publisher Copyright:
© 2017 Wolters Kluwer Health, Inc. All rights reserved.

ASJC Scopus Subject Areas

  • Transplantation

Empreinte numérique

Plonger dans les sujets de recherche 'Of cells and microparticles: Assets and liabilities of HLA antibody detection'. Ensemble, ils forment une empreinte numérique unique.

Citer